HCA Q3 Earnings Beat Estimates on Rising Inpatient Surgery Cases
HCA Healthcare's Q3 earnings rise 42% y/y on stronger patient volumes and rising inpatient surgeries, prompting management to lift its 2025 outlook.
HCA Healthcare: Vital Signs And Technicals Solid, But Valuation Has Topped Out (Downgrade)
HCA Healthcare, Inc. delivered strong Q3 results, beating earnings and revenue expectations, and raised full-year guidance. Despite HCA's outperformance and robust technicals, shares are now near fair value, prompting a downgrade from buy to hold. Upside is limited by valuation, with risks including labor costs, Medicaid changes, and industry competition, though fundamentals remain solid.
HCA Lifts Outlook as Quarterly Profit, Revenue Rise
HCA Healthcare lifted its full-year outlook after logging higher profit and revenue in the third quarter, as same-facility admissions grew.
Will Rising Costs Hurt HCA Healthcare Q3 Earnings? Key Estimates Here
HCA's Q3 earnings to witness solid revenue growth, but rising expenses may weigh on results.
HCA Healthcare, Inc. (HCA) Healthcare, Inc. Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
HCA Healthcare, Inc. (NYSE:HCA ) Healthcare, Inc. Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 2:15 PM EDT Company Participants Mike Marks - CFO & Executive VP Conference Call Participants Stephen Baxter - Wells Fargo Securities, LLC, Research Division Presentation Stephen Baxter Senior Equity Analyst Alright. So good afternoon, everyone.
Why HCA Healthcare (HCA) is a Top Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Here's Why HCA Healthcare (HCA) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why HCA Healthcare (HCA) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Can HCA Healthcare Revive the Market's Weakest Sector?
The healthcare sector has experienced a 0.79% decline year-to-date, making it the worst performer among the S&P 500's 11 sectors and the only one in negative territory. But unlike other market-lagging sectors that have performed better of late (e.g.
HCA: This Healthcare Giant Will Not Make Your Portfolio Sick
HCA Healthcare is the best-managed U.S. hospital chain, offering essential services and resilient financials, making it a strong buy for diversified portfolios. Recent results show robust revenue and EPS growth, with aggressive share repurchases and manageable debt supporting shareholder returns. Valuation is attractive: a 16x multiple on 2025 EPS yields a $416 fair value, implying a 25% total return potential from current levels.
